The developing oligodendrocyte: Key cellular target in brain injury in the premature infant

International Journal of Developmental Neuroscience

Volumn 29, Issue 4, 2011, Pages 423-440

  Volpe, Joseph J ^a   Kinney, Hannah C ^a   Jensen, Frances E ^a   Rosenberg, Paul A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Developing oligodendrocyte; Excitotoxicity; Free radicals; Hypoxia ischemia; Microglial activation; Premature brain injury

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; ESTRADIOL; EXCITATORY AMINO ACID TRANSPORTER 2; FREE RADICAL; GAMMA INTERFERON; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; KAINIC ACID RECEPTOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOPIRAMATE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN K GROUP;

ANTIINFLAMMATORY ACTIVITY; ASTROCYTOSIS; BRAIN CIRCULATION; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM TRANSPORT; ENCEPHALOMALACIA; EXCITOTOXICITY; HUMAN; HYPOCAPNIA; INFLAMMATION; INNATE IMMUNITY; INTRAUTERINE INFECTION; MICROGLIA; MYELINATION; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NEWBORN HYPOXIA; NEWBORN INFECTION; NITROSATIVE STRESS; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; OXYTOSIS; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VERY LOW BIRTH WEIGHT; WHITE MATTER; WHITE MATTER INJURY;

ANIMALS; BRAIN INJURIES; GLUTAMIC ACID; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNITY, INNATE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LEUKOMALACIA, PERIVENTRICULAR; MICROGLIA; OLIGODENDROGLIA; REACTIVE OXYGEN SPECIES;

EID: 79955781842     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.02.012     Document Type: Review

References (213)

1. Aarnoudse-Moens C.S., Weisglas-Kuperus N., van Goudoever J.B., Oosterlaan J. Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 2009, 124:717-728.
2. Agresti C., D'Urso D., Levi G. Reversible inhibitory effects of interferon-γ- and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 1996, 8:1106-1116.
3. Alberdi E., Sanchez-Gomez M.V., Marino A., Matute C. Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol. Dis. 2002, 2:234-243.
4. Albrecht P., Lewerenz J., Dittmer S., Noack R., Maher P., Methner A. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol. Disord. Drug Targets 2010, 9:373-382.
5. Andiman S.E., Haynes R.L., Trachtenberg F.L., Billiards S.S., Folkerth R.D., Volpe J.J., Kinney H.C. The cerebral cortex overlying periventricular leukomalacia: analysis of pyramidal neurons. Brain Pathol. 2010, 20:803-814.
6. Andrews T., Zhang P., Bhat N.R. TNF-α potentiates IFNγ-induced cell death in oligodendrocyte progenitors. J. Neurosci. Res. 1998, 54:574-583.
7. Arnold S., Beyer C. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J. Neurochem. 2009, 110:1-11.
8. Arumugam T.V., Okun E., Tang S.C., Thundyil J., Taylor S.M., Woodruff T.M. Toll-like receptors in ischemia-reperfusion injury. Shock 2009, 32:4-16.
9. Arvin K.L., Han B.H., Du Y., Lin S.-Z., Paul S.M., Holtzman D.M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 2002, 52:54-61.
10. Back S.A., Gan X., Li Y., Rosenberg P.R., Volpe J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 1998, 18(16):6241-6253.
11. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 2001, 21:1302-1312.
12. Back S.A., Craig A.S., Kayton R., Luo N.L., Meshul C., Allcock N., Fern R. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J. Cereb. Blood Flow Metab. 2007, 27:334-347.
13. Back S.A., Craig A., Ling Luo N., Ren J., Akundi R.S., Ribeiro I., Rivkees S.A. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann. Neurol. 2006, 60:696-705.
14. Back S.A., Luo N.L., Mallinson R.A., O'Malley J.P., Wallen L.D., Frei B., Morrow J.D., Petito C.K., Roberts G.H., Murdoch C.T., et al. Selective vulnerability of preterm white matter to oxidative damage defined by F(2)-isoprostanes. Ann. Neurol. 2005, 58:108-120.
15. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 2005, 11:966-972.
16. Baerwald K.D., Popko B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J. Neurosci. Res. 1998, 52:230-239.
17. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., Kalivas P.W. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat. Neurosci. 2003, 6:743-749.
18. Bakiri Y., Burzomato V., Frugier G., Hamilton N.B., Karadottir R., Attwell D. Glutamatergic signaling in the brain's white matter. Neuroscience 2009, 158:266-274.
19. Barger S.W., Goodwin M.E., Porter M.M., Beggs M.L. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 2007, 101:1205-1213.
20. Barks J.D.E., Liu Y.-Q., Shangguan Y., Li J., Pfau J., Silverstein F.S. Impact of indolent inflammation on neonatal hypoxic-ischemic brain injury in mice. Int. J. Dev. Neurosci. 2008, 26:57-65.
21. Baud O., Li J., Zhang Y., Neve R.L., Volpe J.J., Rosenberg P.A. Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur. J. Neurosci. 2004, 20:1713-1726.
22. Baud O., Greene A., Li J., Wang H., Volpe J.J., Rosenberg P.A. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J. Neurosci. 2004, 26:1531-1549.
23. Baud O., Haynes R.F., Wang H., Folkerth R.D., Li J., Volpe J.J., Rosenberg P.A. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur. J. Neurosci. 2004, 20:29-40.
24. Beaino G., Khoshnood B., Kaminski M., Pierrat V., Marret S., Matis J., Ledesert B., Thiriez G., Fresson J., Roze J.C., et al. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev. Med. Child Neurol. 2010, 52:e119-e125.
25. Bell J.E., Becher J.C., Wyatt B., Keeling J.W., McIntosh N. Brain damage and axonal injury in a Scottish cohort of neonatal deaths. Brain 2005, 128:1070-1081.
26. Benarroch E.E. Glutamate transporters: diversity, function, and involvement in neurologic disease. Neurology 2010, 74:259-264.
27. Billiards S.S., Haynes R.L., Folkerth R.D., Trachtenberg F.L., Liu L.G., Volpe J.J., Kinney H.C. Development of microglia in the cerebral white matter of the human fetus and infant. J. Comp. Neurol. 2006, 497:199-208.
28. Billiards S.S., Haynes R.L., Folkerth R.D., Borenstein N.S., Trachtenberg F.L., Rowitch D.H., Ligon K.L., Volpe J.J., Kinney H.C. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 2008, 18:153-163.
29. Brown G.C., Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 2003, 27:325-355.
30. Brown M.S., Eichorst D., Lala-Black B., Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 2009, 124:e681-687.
31. Buchanan M.M., Hutchinson M., Watkins L.R., Yin H. Toll-like receptor 4 in CNS pathologies. J. Neurochem. 2010, 114:13-27.
32. Buller K.M., Carty M.L., Reinebrant H.E., Wixey J.A. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?. J. Neurosci. Res. 2009, 87:599-608.
33. Buntinx M., Moreels M., Vandenabeele F., Lambrichts N., Raus J., Steels P., Stinissen P., Ameloot M. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J. Neurosci. Res. 2004, 76:834-845.
34. Cao Y., Gunn A.J., Bennet L., Wu D., George S., Gluckman P.D., Shao X.-M., Guan J. Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J. Cereb. Blood Flow Metab. 2003, 23:739-747.
35. Chakravarty S., Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 2005, 25:1788-1796.
36. Chang Y.S., Mu D., Wendland M., Sheldon R.A., Vexler Z.S., McQuillen P.S., Ferriero D.M. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr. Res. 2005, 58:106-111.
37. Chau V., Poskitt K.J., McFadden D.E., Bowen-Roberts T., Synnes A., Brant R., Sargent M.A., Soulikias W., Miller S.P. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann. Neurol. 2009, 66:155-164.
38. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17:83-93.
39. Coumans A.B.C., Middelanis J., Garnier Y., Vaihinger H.-M., Leib S.L., Von Duering M.U., Hasaart T.H.M., Jensen A., Berger R. Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr. Res. 2003, 53:770-775.
40. D'Mello C., Le T., Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 2009, 29:2089-2102.
41. Davis P.G., Schmidt B., Roberts R.S., Doyle L.W., Asztalos E., Haslam R., Sinha S., Tin W. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J. Pediatr. 2010, 156:382-387.
42. Degos V., Favrais G., Kaindl A.M., Peineau S., Guerrot A.M., Verney C., Gressens P. Inflammation processes in perinatal brain damage. J. Neural Transm. 2010, 117:1009-1017.
43. Degterev A., Yuan J. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 2008, 9:378-390.
44. Deng W., Rosenberg P.A., Volpe J.J., Jensen F.E. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:6801-6806.
45. Deng W., Wang H., Rosenberg P.A., Volpe J.J., Jensen F.E. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7751-7756.
46. Deng W., Neve R.L., Rosenberg P.A., Volpe J.J., Jensen F.E. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit composition and cAMP-response element-binding protein regulate oligodendrocyte excitotoxicity. J. Biol. Chem. 2006, 281:36004-36011.
47. DeSilva T.M., Kinney H.C., Borenstein N.S., Trachtenberg F., Irwin N., Volpe J.J., Rosenberg P.A. The glutamate transporter is transiently expressed in developing human cerebral white matter. J. Comp. Neurol. 2007, 501:879-890.
48. DeSilva T.M., Billards S.S., Borenstein N.S., Trachtenberg F.L., Volpe J.J., Kinney H.C., Rosenberg P.A. Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. J. Comp. Neurol. 2008, 508:238-248.
49. Dommergues M.-A., Gallego J., Evrard P., Gressens P. Iron supplementation aggravates periventricular cystic white matter lesions in newborn mice. Eur. J. Paediatr. Neurol. 1998, 2:313-318.
50. Doyle L.W., Roberts G., Anderson P.J. Outcomes at age 2 years of infants<28 weeks' gestational age born in Victoria in 2005. J. Pediatr. 2010, 156:49-53. e41.
51. Eklind S., Arvidsson P., Hagberg H., Mallard C. The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats. Dev. Neurosci. 2004, 26:61-67.
52. Eklind S., Mallard C., Arvidsson P., Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr. Res. 2005, 58:112-116.
53. Eklind S., Mallard C., Leverin A.-L., Gilland E., Blomgren K., Mattsby-Baltzer I., Hagberg H. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur. J. Neurosci. 2001, 13:1101-1106.
54. Eklind S., Hagberg H., Wang X., Savman K., Leverin A.L., Hedtjarn M., Mallard C. Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr. Res. 2006, 60:161-168.
55. Falsig J., van Beek J., Hermann C., Leist M. Molecular basis for detection of invading pathogens in the brain. J. Neurosci. Res. 2008, 86:1434-1447.
56. Fan L.W., Pang Y., Lin S.Y., Tien L.T., Ma T.G., Rhodes P.G., Cai Z.W. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 2005, 82:71-82.
57. Feng Y., Piletz J.E., LeBlanc M.H. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 2002, 52:606-611.
58. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci. 2000, 20:34-42.
59. Folkerth R.D., Keefe R.J., Haynes R.L., Trachtenberg F.L., Volpe J.J., Kinney H.C. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol. 2004, 14:265-274.
60. Folkerth R.D., Haynes R.L., Borenstein N.S., Belliveau R.A., Trachtenberg F., Rosenberg P.A., Volpe J.J., Kinney H.C. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J. Neuropathol. Exp. Neurol. 2004, 63:990-999.
61. Follett P.L., Rosenberg P.A., Volpe J.J., Jensen F.E. NBQX attenuates excitotoxic injury in developing white matter. J. Neurosci. 2000, 20:9235-9241.
62. Follett P.L., Deng W., Dai W., Talos D.M., Massillon L.J., Rosenberg P.A., Volpe J.J., Jensen F.E. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J. Neurosci. 2004, 24:4412-4420.
63. Gendron F.-P., Chalimoniuk M., Strosznajder J., Shen S., Gonzalez F.A., Weisman G.A., Sun G.Y. P2X7 nucleotide receptor activation enhances IFNγ-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 2003, 87:344-352.
64. Gerstner B., L.J.M., Lee J., DeSilva T.M., Jensen F.E., Volpe J.J., Rosenberg P.A. 17β-Estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J. Neurosci. Res. 2009, 87:2078-2086.
65. Gerstner B., Sifringer M., Dzietko M., Schuller A., Lee J., Simons S., Obladen M., Volpe J.J., Rosenberg P.A., Felderhoff-Mueser U. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann. Neurol. 2007, 61:562-573.
66. Girard S., Kadhim H., Beaudet N., Sarret P., Sebire G. Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel animal model for cerebral palsy in very premature infants. Neuroscience 2009, 158:673-682.
67. Glier C., Dzietko M., Bittigau P., Jarosz B., Korobowicz E., Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp. Neurol. 2004, 187:403-409.
68. Groenendaal F., Termote J., van der Heide-Jalving M., van Haastert I., de Vries L. Complications affecting preterm neonates from 1991 to 2006: what have we gained?. Acta Paediatr. 2010, 99:354-358.
69. Guan J., Thomas G.B., Lin H., Mathai S., Bachelor D.C., George S., Gluckman P.D. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats. Neuropharmacology 2004, 47:892-903.
70. Hagberg H., Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr. Opin. Neurol. 2005, 18:117-123.
71. Hagberg H., Gilland E., Bona E., Hanson L.A., Hahn-Zoric M., Blennow M., Holst M., McRae A., Soder O. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr. Res. 1996, 40:603-609.
72. Ham R.G., McKeehan W.L. Media and growth requirements. Methods Enzymol. 1979, 58:44-93.
73. Haynes R.L., Billiards S.S., Borenstein N.S., Volpe J.J., Kinney H.C. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr. Res. 2008, 63:656-661.
74. Haynes R.L., Folkerth R.D., Trachtenberg F.L., Volpe J.J., Kinney H.C. Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia. Acta Neuropathol. 2009, 118:391-399.
75. Haynes R.L., Folkerth R.D., Keefe R., Sung I., Swzeda L.I., Rosenberg P.A., Volpe J.J., Kinney H.C. Nitrosative and oxidative injury to premyelinating oligodendrocytes is accompanied by microglial activation in periventricular leukomalacia in the human premature infant. J. Neuropathol. Exp. Neurol. 2003, 62:441-450.
76. Hennebert O., Marret S., Carmeliet P., Gressens P., Laquerriere A., Leroux P. Role of tissue-derived plasminogen activator (T-PA) in an excitotoxic mouse model of neonatal white matter lesions. J. Neuropathol. Exp. Neurol. 2004, 63:53-63.
77. Heron M., Sutton P.D., Xu J., Ventura S.J., Strobino D.M., Guyer B. Annual summary of vital statistics: 2007. Pediatrics 2010, 125:4-15.
78. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., Yuan J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
79. Ho Y., Samarasinghe R., Knoch M.E., Lewis M., Aizenman E., DeFranco D.B. Selective inhibition of mitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death. Mol. Pharmacol. 2008, 74:1141-1151.
80. Hudome S., Palmer C., Roberts R.L., Mauger D., Housman C., Towfighi J. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr. Res. 1997, 41:607-616.
81. Husson I., Rangon C.M., Lelievre V., Bemelmans A.P., Sachs P., Mallet J., Kosofsky B.E., Gressens P. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb. Cortex 2005, 15:250-261.
82. Iida K., Takashima S., Ueda K. Immunohistochemical study of myelination and oligodendrocyte in infants with periventricular leukomalacia. Pediatr. Neurol. 1995, 13:296-304.
83. Ikeda T., Mishima K., Aoo N., Egashira N., Iwasaki K., Fujiwara M., Ikenoue T. Combination treatment of neonatal rats with hypoxia-ischemia and endotoxin induces long-lasting memory and learning impairment that is associated with extended cerebral damage. Am. J. Obstet. Gynecol. 2004, 191:2132-2141.
84. Inder T.E., Mocatta T., Darlow B., Spencer C., Volpe J.J. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr. Res. 2002, 52:213-218.
85. Itoh T., Beesley J., Itoh A., Cohen A.S., Kavanaugh B., Coulter D.A., Grinspan J.B., Pleasure D. AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J. Neurochem. 2002, 81:390-402.
86. Jensen F.E. Role of glutamate receptors in periventricular leukomalacia. J. Child Neurol. 2005, 20:950-959.
87. Jin G., Arai K., Murata Y., Wang S., Stins M.F., Lo E.H., van Leyen K. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 2008, 39:2538-2543.
88. Johnson S., Hollis C., Kochhar P., Hennessy E., Wolke D., Marlow N. Autism spectrum disorders in extremely preterm children. J. Pediatr. 2010, 156:525-531. e522.
89. Johnson S., Fawke J., Hennessy E., Rowell V., Thomas S., Wolke D., Marlow N. Neurodevelopmental disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics 2009, 124:e249-e257.
90. Kadhim H., Khalifa M., Deltenre P., Casimir G., Sebire G. Molecular mechanisms of cell death in periventricular leukomalacia. Neurology 2006, 67:293-299.
91. Kadhim H.J., Tabarki B., Verellen G., De Prez C., Rona A.-M., Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
92. Kakita H., Hussein M.H., Yamada Y., Henmi H., Kato S., Kobayashi S., Ito T., Kato I., Fukuda S., Suzuki S., et al. High postnatal oxidative stress in neonatal cystic periventricular leukomalacia. Brain Dev. 2009, 31:641-648.
93. Karadottir R., Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145:1426-1438.
94. Karadottir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
95. Kellert B.A., McPherson R.J., Juul S.E. A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr. Res. 2007, 61:451-455.
96. Khwaja O., Volpe J.J. Pathogenesis of cerebral white matter injury of prematurity. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93:F153-F161.
97. Kinney, H.C., Andiman, S.E., Haynes, R.L., Xu, G., Folkerth, R.D., Sleeper, L.A., Volpe, J.J. Deficit of white matter neurons in periventricular leukomalacia: implications for cognitive abnormalities in preterm survivors. Brain Pathol., submitted for publication.
98. Kraus R.L., Pasieczny R., Lariosa-Willingham K., Turner M.S., Jiang A., Trauger J.W. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J. Neurochem. 2005, 94:819-827.
99. Kuban K., Sanocka U., Leviton A., Allred E.N., Pagano M., Dammann O., Share J., Rosenfeld D., Abiri M., DiSalvo D., et al. White matter disorders of prematurity: association with intraventricular hemorrhage and ventriculomegaly. J. Pediatr. 1999, 134:539-546.
100. LaFerla F.M., Sugarman M.C., Lane T.E., Leissring M.A. Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J. Mol. Neurosci. 2000, 15:45-59.
101. Larouche A., Roy M., Kadhim H., Tsanaclis A.M., Fortin D., Sebire G. Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Dev. Neurosci. 2005, 27:134-142.
102. Lechpammer M., Manning S.M., Samonte F., Nelligan J., Sabo E., Talos D.M., Volpe J.J., Jensen F.E. Minocycline treatment following hypoxic-ischemic injury attenuates white matter injury in a rodent model of periventricular leukomalacia. Neuropathol. Appl. Neurobiol. 2008, 34:379-393.
103. Lee S.M., Yune T.Y., Kim S.J., Kim Y.C., Oh Y.J., Markelonis G.J., Oh T.H. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 2004, 91:568-578.
104. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
105. Lehnardt S., Massillon L., Follet P., Jensen F.E., Ratan R.R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8514-8519.
106. Leviton A., Allred E.N., Kuban K.C., Hecht J.L., Onderdonk A.B., O'Shea T.M., Paneth N. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. The ELGAN study. Pediatr. Res. 2010, 67:95-101.
107. Li J., Wang H., Rosenberg P.A. Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J. Neurosci. Res. 2009, 87:1997-2005.
108. Li J., Baud O., Vartanian T., Volpe J.J., Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9936-9941.
109. Li J., Ramenaden R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. TNFα mediates LPS-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 2008, 28:5321-5330.
110. Li J., Lin J.C., Wang H., Peterson J.W., Furie B.C., Furie B., Booth S.L., Volpe J.J., Rosenberg P.S. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J. Neurosci. 2003, 23:5816-5826.
111. Li Y.P., Maher P., Schubert D.H. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 1997, 19:453-463.
112. Ligam P., Haynes R.L., Folkerth R.D., Liu L., Yang M., Volpe J.J., Kinney H.C. Thalamic damage in periventricular leukomalacia: novel pathologic observations relevant to cognitive deficits in survivors of prematurity. Pediatr. Res. 2009, 65:524-529.
113. Limperopoulos C. Autism spectrum disorders in survivors of extreme prematurity. Clin. Perinatol. 2009, 36:791-805.
114. Lin S., Cox H.J., Rhodes P.G., Cai Z. Neuroprotection of alpha-phenyl-n-tert-butyl-nitrone on the neonatal white matter is associated with anti-inflammation. Neurosci. Lett. 2006, 405:52-56.
115. Lin S.Y., Fan L.W., Pang Y., Rhodes P.G., Mitchell H.J., Cai Z.W. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 2005, 1063:15-26.
116. Lin W., Kemper A., Dupree J.L., Harding H.P., Ron D., Popko B. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006, 129:1306-1318.
117. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 2002, 8:620-624.
118. Liu H.-N., Giasson B.I., Mushynski W.E., Almazan G. AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain and caspase 3. J. Neurochem. 2002, 82:398-409.
119. Liu X.-H., Eun B.-L., Silverstein S., Barks J.D. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr. Res. 1996, 6:797-803.
120. Loeliger M., Watson C.S., Reynolds J.D., Penning D.H., Harding R., Bocking A.D., Rees S.M. Extracellular glutamate levels and neuropathology in cerebral white matter following repeated umbilical cord occlusion in the near term fetal sheep. Neuroscience 2003, 116:705-714.
121. Lyng K., Braakhuis M., Froen J.F., StrayPedersen B., Saugstad O.D. Inflammation increases vulnerability to hypoxia in newborn piglets: effect of reoxygenation with 21% and 100% O-2. Am. J. Obstet. Gynecol. 2005, 192:1172-1178.
122. Manning F.A. General principles and applications of ultrasonography. Maternal-Fetal Medicine, Principles and Practice 2004, 315-356. WB Saunders, Philadelphia. R.K. Creasy, R. Resnik, J.D. Iams (Eds.).
123. Manning, S.M., Boll, G., Fitzgerald, E., Selip, D., Volpe, J.J., Jensen, F. The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain. Int J Devl Neuroscience, submitted for publication.
124. Manning S.M., Talos D.M., Zhou C., Selip D.R., Park H.-K., Park C.-J., Volpe J.J., Jensen F.E. NMDA receptor blockade with memantine attenuates white matter deficits in a rat model of periventricular leukomalacia. J. Neurosci. 2008, 28:6670-6678.
125. Matute C. Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol. Med. 2006, 12:289-292.
126. Matute C., Domercq M., Sanchez-Gomez M.V. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006, 53:212-224.
127. Matute C., Alberdi E., Domercq M., Sanchez-Gomez M.V., Perez-Samartin A., Rodriguez-Antiguedad A., Perez-Cerda F. Excitotoxic damage to white matter. J. Anat. 2007, 210:693-702.
128. McClure M.M., Riddle A., Manese M., Luo N.L., Rorvik D.A., Kelly K.A., Barlow C.H., Kelly J.J., Vinecore K., Roberts C.T., et al. Cerebral blood flow heterogeneity in preterm sheep: lack of physiologic support for vascular boundary zones in fetal cerebral white matter. J. Cereb. Blood Flow Metab. 2008, 28:995-1008.
129. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 1998, 4:291-297.
130. Micu I., Jiang Q., Coderre E., Ridsdale A., Zhang L., Woulfe J., Yin X., Trapp B.D., McRory J.E., Rehak R., et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006, 439:988-992.
131. Monier A., Evrard P., Gressens P., Verney C. Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation. J. Comp. Neurol. 2006, 499:565-582.
132. Morimoto N., Shimazawa M., Yamashima T., Nagal H., Hara H. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res. 2005, 1044:8-15.
133. Msall M.E. Central nervous system connectivity after extreme prematurity: understanding autistic spectrum disorder. J. Pediatr. 2010, 156:519-521.
134. Muglia L.J., Katz M. The enigma of spontaneous preterm birth. N. Engl. J. Med. 2010, 362:529-535.
135. Munck P., Haataja L., Maunu J., Parkkola R., Rikalainen H., Lapinleimu H., Lehtonen L., Group T.P.S. Cognitive outcome at 2 years of age in Finnish infants with very low birth weight born between 2001 and 2006. Acta Paediatr. 2010, 99:359-366.
136. Muramatsu K., Sheldon R.A., Black S.M., Tauber M., Ferriero D.M. Nitric oxide synthase activity and inhibition after neonatal hypoxia ischemia in the mouse brain. Dev. Brain Res. 2000, 123:119-127.
137. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558.
138. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention. J. Neurosci. 1993, 13:1441-1453.
139. Owens T., Bechmann I., Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J. Neuropathol. Exp. Neurol. 2008, 67:1113-1121.
140. Ozawa H., Nishida A., Mito T., Takashima S. Development of ferritin-positive cells in cerebrum of human brain. Pediatr. Neurol. 1994, 10:44-48.
141. Paintlia M.K., Paintlia A.S., Contreras M.A., Singh I., Singh A.K. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp. Neurol. 2008, 210:560-576.
142. Pallast S., Arai K., Pekcec A., Yigitkanli K., Yu Z., Wang X., Lo E.H., van Leyen K. Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J. Cereb. Blood Flow Metab. 2010, 30:1157-1167.
143. Pang Y., Cai Z.W., Rhodes P.G. Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J. Neurosci. Res. 2005, 80:226-234.
144. Pang Y., Zheng B., Campbell L.R., Fan L.W., Cai Z., Rhodes P.G. IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain. Pediatr. Res. 2010, 67:579-584.
145. Peeters-Scholte C.P., Koster J., Veldhuis W., van denTweel E., Zhu C.L., Kops N., Blomgren K., Bar D., Offers S.V.B., Hagberg H., et al. Neuroprotection by selective nitric oxide synthase inhibition at 24h after perinatal hypoxia-ischemia. Stroke 2002, 33:2304-2310.
146. Pi R.B., Li W.M., Lee N.T.K., Chan H.H.N., Pu Y.M., Chan L.N., Sucher N.J., Chang D.C., Li M.T., Han Y.F. Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J. Neurochem. 2004, 91:1219-1230.
147. Pierson C.R., Folkerth R.D., Billards S.S., Trachtenberg F.L., Drinkwater M.E., Volpe J.J., Kinney H.C. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol. 2007, 114:619-631.
148. Pitt D., Nagelmeier I.E., Wilson H.C., Raine C.S. Glutamate uptake by oligodendrocytes. Implications for excitotoxicity in multiple sclerosis. Neurology 2003, 61:1113-1120.
149. Popko B., Baerwald K.D. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem. Res. 1999, 24:331-338.
150. Ransohoff R.M. Microgliosis: the questions shape the answers. Nat. Neurosci. 2007, 10:1507-1509.
151. Rees S., Hale N., De Matteo R., Cardamone L., Tolcos M., Loeliger M., Mackintosh A., Shields A., Probyn M., Greenwood D., et al. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury. J. Neuropathol. Exp. Neurol. 2010, 69:306-319.
152. Rezaie P., Dean A., Male D., Ulfig N. Microglia in the cerebral wall of the human telencephalon at second trimester. Cereb. Cortex 2005, 15:938-949.
153. Riddle A., Luo N.L., Manese M., Beardsley D.J., Green L., Rorvik D.A., Kelly K.A., Barlow C.H., Kelly J.J., Hohimer A.R., et al. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J. Neurosci. 2006, 26:3045-3055.
154. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17:13-19.
155. Roberts G., Anderson P.J., Doyle L.W. Neurosensory disabilities at school age in geographic cohorts of extremely low birth weight children born between the 1970s and the 1990s. J. Pediatr. 2009, 154:829-834. e821.
156. Robinson S., Li Q., Dechant A., Cohen M.L. Neonatal loss of gamma-aminobutyric acid pathway expression after human perinatal brain injury. J. Neurosurg. 2006, 104:396-408.
157. Rosenberg P.A., Dai W., Gan X.D., Ali S., Fu J.M., Back S.A., Sanchez R.M., Segal M.M., Follett P.L., Jensen F.E., et al. Mature myelin basic protein expressing oligodendrocytes are insensitive to kainate toxicity. J. Neurosci. Res. 2003, 71:237-245.
158. Rousset C.I., Kassem J., Olivier P., Chalon S., Gressens P., Saliba E. Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury. J. Neuropathol. Exp. Neurol. 2008, 67:994-1000.
159. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
160. Sanchez-Gomez M.V., Alberdi E., Ibarretxe G., Torre I., Matute C. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J. Neurosci. 2003, 23:9519-9528.
161. Savman K., Nilsson U.A., Thoresen M., Kjellmer I. Non-protein-bound iron in brain interstitium of newborn pigs after hypoxia. Dev. Neurosci. 2005, 27:176-184.
162. Savman K., Nilsson U.A., Blennow M., Kjellmer I., Whitelaw A. Non-protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilation. Pediatr. Res. 2001, 49:208-212.
163. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., Solimano A., Tin W. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 2007, 357:1893-1902.
164. Schubert D., Piasecki D. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 2001, 21:7455-7462.
165. Segovia K.N., McClure M., Moravec M., Luo N.L., Wan Y., Gong X., Riddle A., Craig A., Struve J., Sherman L.S., et al. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann. Neurol. 2008, 63:520-530.
166. Seiler A., Schneider M., Forster H., Roth S., Wirth E.K., Culmsee C., Plesnila N., Kremmer E., Radmark O., Wurst W., et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008, 8:237-248.
167. Sfaello I., Daire J.L., Husson I., Kosofsky B., Sebag G., Gressens P. Patterns of excitotoxin-induced brain lesions in the newborn rabbit: a neuropathological and MRI correlation. Dev. Neurosci. 2005, 27:160-168.
168. Shah D.K., Doyle L.W., Anderson P.J., Bear M., Daley A.J., Hunt R.W., Inder T.E. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J. Pediatr. 2008, 153:170-175. 175, e171.
169. Shankaran S., Langer J.C., Kazzi S.N., Laptook A.R., Walsh M. Cumulative index of exposure to hypocarbia and hyperoxia as risk factors for periventricular leukomalacia in low birth weight infants. Pediatrics 2006, 118:1654-1659.
170. Sloane J.A., Blitz D., Margolin Z., Vartanian T. A clear and present danger: endogenous ligands of toll-like receptors. Neuromol. Med. 2009, 12:149-163.
171. Sloane J.A., Batt C., Ma Y., Harris Z.M., Trapp B., Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11555-11560.
172. Sola A., Wen T.C., Hamrick S.E., Ferriero D.M. Potential for protection and repair following injury to the developing brain: a role for erythropoietin?. Pediatr. Res. 2005, 57:110R-117R.
173. Sola A., Rogido M., Lee B.H., Genetta T., Wen T.C. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr. Res. 2005, 57:481-487.
174. Song Y., Wei E.Q., Zhang W.P., Zhang L., Liu J.R., Chen Z. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport 2004, 15:2181-2184.
175. Soul J.S., Hammer P.E., Tsuji M., Saul P., Bassan H., Limperopoulos C., Moore M., Walter G., Akins P., Ringer S.A., et al. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr. Res. 2007, 61:467-473.
176. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., GuibaTziampiri O. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res. 2005, 1045:22-30.
177. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., et al. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 2000, 275:12200-12206.
178. Statler P.A., McPherson R.J., Bauer L.A., Kellert B.A., Juul S.E. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr. Res. 2007, 61:671-675.
179. Stoll B.J., Hansen N.I., AdamsChapman I., Fanaroff A.A., Hintz S.R., Vohr B., Higgins R.D. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
180. Stoll B.J., Hansen N.I., Higgins R.D., Fanaroff A.A., Duara S., Goldberg R., Laptook A., Walsh M., Oh W., Hale E. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr. Infect. Dis. J. 2005, 24:635-639.
181. Tahraoui S.L., Marret S., Bodenant C., Leroux P., Dommergues M.A., Evrard P., Gressens P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol. 2001, 11:56-71.
182. Takahashi J.L., Giuliani F., Power C., Imai Y., Yong V.W. Interleukin-1β promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol. 2003, 53:588-595.
183. Talos D.M., Fishman R.E., Park H., Folkerth R.D., Follett P.L., Volpe J.J., Jensen F.E. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. J. Comp. Neurol. 2006, 497:42-60.
184. Talos D.M., Follett P.L., Folkerth R.D., Fishman R.E., Trachtenberg F.L., Volpe J.J., Jensen F.E. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J. Comp. Neurol. 2006, 497:61-77.
185. Taylor D.L., Pirianov G., Holland S., McGinnity C.J., Norman A.L., Reali C., Diemel L.T., Gveric D., Yeung D., Mehmet H. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J. Neurosci. Res. 2010, 88:1632-1644.
186. Tekkok S.B., Goldberg M.P. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J. Neurosci. 2001, 21:4237-4248.
187. Tekkok S.B., Ye Z., Ransom B.R. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J. Cereb. Blood Flow Metab. 2007, 9:1540-1552.
188. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 2001, 21:2580-2588.
189. Tutak E., Satar M., Zorludemir S., Erdogan S., Yapicioglu H., Narli N. Neuroprotective effects of indomethacin and aminoguanidine in the newborn rats with hypoxic-ischemic cerebral injury. Neurochem. Res. 2005, 30:937-942.
190. van den Tweel E.R.W., van Bel F., Kavelaars A., Peeters-Scholte C.M.P.C.D., Haumann J., Nijboer C.H.A., Heijnen C.J., Groenendaal F. Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats. J. Cereb. Blood Flow Metab. 2005, 25:67-74.
191. van Leyen K., Arai K., Jin G., Kenyon V., Gerstner B., Rosenberg P.A., Holman T.R., Lo E.H. Novel lipoxygenase inhibitors as neuroprotective reagents. J. Neurosci. Res. 2008, 86:904-909.
192. Vartanian T., Li Y., Zhao M.J., Stefansson K. Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1995, 1:732-743.
193. Volpe J.J. Neonatal encephalitis and white matter injury: more than just inflammation?. Ann. Neurol. 2008, 64:232-236.
194. Volpe J.J. Neurology of the Newborn 2008, Elsevier, Philadelphia. 5th ed.
195. Volpe J.J. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J. Pediatr. 2008, 153:160-163.
196. Volpe J.J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009, 8:110-124.
197. Wang H., Li J., Follett P.L., Zhang Y., Cotanche D.A., Jensen F.E., Volpe J.J., Rosenberg P.A. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur. J. Neurosci. 2004, 20:2049-2058.
198. Wang L.W., Chang Y.C., Lin C.Y., Hong J.S., Huang C.C. Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain. Pediatr. Res. 2010, 68:41-47.
199. Wang X., Hagberg H., Zhu C., Jacobsson B., Mallard C. Effects of intrauterine inflammation on the developing mouse brain. Brain Res. 2007, 1144:180-185.
200. Wang X., Hagberg H., Nie C., Zhu C., Ikeda T., Mallard C. Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J. Neuropathol. Exp. Neurol. 2007, 66:552-561.
201. Wang X., Stridh L., Li W., Dean J., Elmgren A., Gan L., Eriksson K., Hagberg H., Mallard C. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J. Immunol. 2009, 183:7471-7477.
202. Wang X., Svedin P., Nie C., Lapatto R., Zhu C., Gustavsson M., Sandberg M., Karlsson J.O., Romero R., Hagberg H., et al. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann. Neurol. 2007, 61:263-271.
203. Wang X.Y., Zhu C.L., Wang X.H., Gerwien J.G., Schrattenholz A., Sandberg M., Leist M., Blomgren K. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J. Neurochem. 2004, 91:900-910.
204. Welin A.K., Svedin P., Lapatto R., Sultan B., Hagberg H., Gressens P., Kjellmer I., Mallard C. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr. Res. 2007, 61:153-158.
205. Wu Y.W., Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy. A meta-analysis. JAMA 2000, 284:1417-1424.
206. Yanowitz T.D., Potter D.M., Bowen A., Baker R.W., Roberts J.M. Variability in cerebral oxygen delivery is reduced in premature neonates exposed to chorioamnionitis. Pediatr. Res. 2006, 59:299-304.
207. Yonezawa M., Back S.A., Gan X., Rosenberg P.A., Volpe J.J. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J. Neurochem. 1996, 67:566-573.
208. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., Beesley J., Pleasure D. Non-N-methyl-d-aspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury. Brain Res. 2000, 854:207-215.
209. Yue X., Mehmet H., Penrice J., Cooper C., Cady E., Wyatt J.S., Raynolds E.O.R., Edwards A.D., Squier M.V. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischemia. Neuropathol. Appl. Neurobiol. 1997, 23:16-25.
210. Zhang R.I., Chopp M., Li Y., Zalonga C., Jiang M., Jones M., Miyasaka M., Ward P. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 1994, 44:1747-1751.
211. Zhang Y., Aizenman E., DeFranco D.B., Rosenberg P.A. Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death. Mol. Med. 2007, 13:350-355.
212. Zhang Y., Wang H., Li J., Jimenez D.A., Levitan E.S., Aizenman E., Rosenberg P.A. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J. Neurosci. 2004, 24:10616-10627.
213. Zhang Y., Wang H., Li J., Dong L., Xu P., Chen W., Neve R.L., Volpe J.J., Rosenberg P.A. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes. J. Biol. Chem. 2006, 281:9460-9470.